华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03320 华润医药

已收盘 04-30 16:08:13

5.250

+0.010

+0.19%

最高5.290	最低5.170	成交量1,416万
今开5.210	昨收5.240	日振幅2.29%
总市值329.86亿	流通市值329.83亿	总股本62.83亿
成交额7,391万	换手率0.23%	流通股本62.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":5.25,"timestamp":1777536493006,"preClose":5.24,"halted":0,"volume":14164500,"delay":0,"changeRate":0.0019083969465648447,"floatShares":6282510461,"shares":6283000000,"eps":0.643391,"marketStatus":"已收盘","change":0.01,"latestTime":"04-30 16:08:13","open":5.21,"high":5.29,"low":5.17,"amount":73911653,"amplitude":0.022901,"askPrice":5.25,"askSize":1496000,"bidPrice":5.23,"bidSize":84500,"shortable":3,"etf":0,"ttmEps":0.715972,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":5,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":5.24,"dividendRate":0.041857,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.719319,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320","defaultTab":"news","newsList":[{"id":"2630045371","title":"华润医药(03320)附属华润医药商业完成发行14亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2630045371","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630045371?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:32","pubTimestamp":1777368769,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，本公司的非全资附属公司华润医药商业集团有限公司(华润医药商业)已完成于中国公开发行第二期2026年公司债券。本金额人民币14亿元的第二期2026年公司债券已发行，期限3年，票面年利率为1.65%。发行第二期2026年公司债券所募集的所得款项净额将用于生产性支出，包括补充营运资金、偿还计息债务、项目投资以及符合适用法律法规的其他用途。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435315.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630356686","title":"港股异动 | 华润医药(03320)早盘跌超5% 旗下多家公司发布一季度业绩 昆药集团首次一季度亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2630356686","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630356686?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:18","pubTimestamp":1777259883,"startTime":"0","endTime":"0","summary":"华润医药(03320)早盘跌超5%，截至发稿，跌5.54%，报54.6港元，成交额8960.6万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260427/20260427111827_60015.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260427/20260427111827_60015.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","BK4588","600422","BK1191","BK0239","BK0188","BK1570","BK0028","VXUS","BK0060","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140797957","title":"异动解读 | 华润医药盘中大跌5.02%，旗下子公司一季度业绩承压拖累股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1140797957","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140797957?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:04","pubTimestamp":1777259085,"startTime":"0","endTime":"0","summary":"华润医药今日盘中股价大跌5.02%，引起了市场的广泛关注。消息面上，此次股价下跌主要与公司旗下多家子公司近期披露的一季度业绩表现分化、整体承压有关。这两家重要子公司的业绩疲软，直接拖累了市场对华润医药集团的整体业绩预期。但昆药集团的显著亏损与华润三九的利润下滑，共同对市场情绪构成了压力，导致股价在交易时段内出现显著下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186809146","title":"华润医药旗下博雅生物季度营收32.11亿元 净利润达3000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186809146","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186809146?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:19","pubTimestamp":1777033154,"startTime":"0","endTime":"0","summary":"华润医药集团旗下控股子公司博雅生物最新季度财务数据显示，公司实现未经审计营业收入32.11亿元人民币，净利润录得3000万元。作为血液制品行业的领军企业，博雅生物本季度业绩展现出稳健的经营态势。\n从财务结构来看，公司营收规模保持较高水平，净利润表现符合市场预期。在医药行业政策持续优化的背景下，博雅生物通过精细化管理和技术创新，持续巩固其在血液制品领域的技术优势和市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0197","03320","BK1570","300294","BK0046","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629845690","title":"华润医药(03320)：昆药集团一季度净亏损1.45亿元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2629845690","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629845690?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:29","pubTimestamp":1777030156,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布昆药集团截止2026年3月31日止3个月财务业绩，该公司取得营业总收入8.36亿元，同比减少48.01%;净亏损1.45亿元，去年同期溢利1.14亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK1191","BK0028","03320","BK1570","BK0239","600422","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179753924","title":"华润医药2026年第一季度营收81.30亿元，经调整净利润12.09亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179753924","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179753924?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:28","pubTimestamp":1777030086,"startTime":"0","endTime":"0","summary":"本季度信息\n华润医药于2026年4月24日公布旗下子公司华润三九截至2026年3月31日止三个月的财务数据显示，营收为81.30亿元（去年同期为68.54亿元），同比增长18.60%。经调整净利润录得12.09亿元（去年同期为13.31亿元），同比下降9.20%。\n同期，公司现金及现金等价物减少13.18亿元，而上年同期增加12.47亿元；截至报告期末，现金及现金等价物为31.98亿元。公告同时显示，截至2026年3月31日，总资产为581.42亿元，较上一年末有所下降。\n由于公告未披露毛利率、销售及管理费用率、研发投入占比等指标，具体成本结构变化暂无更多信息。\n","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175556613","title":"华润医药2026年第一财季营收8.36亿元，净利润-1.45亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175556613","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175556613?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:26","pubTimestamp":1777030002,"startTime":"0","endTime":"0","summary":"本季度信息\n华润医药公布的财报显示，2026年第一财季营收为8.36亿元，同比上一年同期的16.08亿元下降约48.05%。同期净利润为-1.45亿元，而上一财年同期录得1.14亿元，同比下降约227.63%，从盈转亏。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139162852","title":"华润医药2026年第一季度营收10.36亿元，经调整净利润3.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139162852","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139162852?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:45","pubTimestamp":1777023920,"startTime":"0","endTime":"0","summary":"本季度信息\n截至2026年3月31日，华润医药实现营收10.36亿元，同比下降12.50%。同期经调整净利润为3.12亿元，同比上升1.71%。报告期内，公司现金及现金等价物净增加额约为1.19亿元，高于上一年同期的0.47亿元。期末现金及现金等价物余额约为8.28亿元，去年同期为6.99亿元。\n截至2026年3月31日，公司总资产71.60亿元，总负债21.39亿元，所有者权益50.21亿元，较2025年年底均有一定幅度提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155848008","title":"华润医药2026年第一财季营收28.07亿元，净利润5.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155848008","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155848008?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:43","pubTimestamp":1777023809,"startTime":"0","endTime":"0","summary":"本季度信息\n华润医药于2026年4月24日发布截至2026年3月31日止三个月的财务业绩。报告期内，营收为28.07亿元（2025年同期为30.79亿元），同比略有下降。净利润为5.01亿元（2025年同期为5.23亿元），同比出现小幅回落。\n本季度现金及现金等价物净增加额达到6.58亿元（2025年同期为2.72亿元），期末现金及现金等价物余额为25.66亿元（2025年同期为31.10亿元）。截至2026年3月31日，公司总资产约180.07亿元，总负债约50.05亿元，所有者权益约130.02亿元。\n","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629081448","title":"华润医药(03320)：东阿阿胶一季度净利润4.55亿元 同比增长7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629081448","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629081448?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:37","pubTimestamp":1777023465,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布东阿阿胶股份有限公司(东阿阿胶)截至2026年3月31日止3个月业绩，营业总收入约18.14亿元，同比增长5.52%;净利润4.55亿元，同比增长7.12%。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["000423","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119216086","title":"华润医药2026年第一季度营收18.14亿元，经调整净利润4.55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119216086","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119216086?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:37","pubTimestamp":1777023464,"startTime":"0","endTime":"0","summary":"本季度信息\n截至2026年3月31日，华润医药实现营收18.14亿元，同比增长约5.50%。经调整净利润4.55亿元，同比增长约7.11%。报告期内，现金及现金等价物净增加额为12.15亿元，相较上一年同期的3.91亿元增幅约211%。期末现金及现金等价物余额达46.21亿元。\n同时，总资产为135.52亿元，总负债为27.13亿元。上述财务数据由华润医药的附属公司东阿阿胶股份有限公司根据中国公认会计准则编制并披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627765292","title":"华润医药(03320)附属完成发行15亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2627765292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627765292?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:18","pubTimestamp":1776338293,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布，公司的全资附属公司华润医药控股有限公司已根据中国证券监督管理委员会的批复( 证监许可[ 2025 ] 1457号 )于中华人民共和国发行首期2026年公司债券，该批复同意华润医药控股于中国向合资格投资者公开发行本金总额不超过人民币100亿元的公司债券。本金额人民币15亿元的首期2026年公司债券已发行，期限3年，票面年利率为1.65 %。所得净额将用于生产性支出，包括偿还公司债务、补充营运资金、项目开发与营运支出、与科技创新相关的投资以及符合适用法律法规的其他用途。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195377338","title":"华润医药更新3月股份变动月报表，股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1195377338","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195377338?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:12","pubTimestamp":1775034774,"startTime":"0","endTime":"0","summary":"华润医药（03320）于2026年4月1日发布截至2026年3月31日的月度股份变动报告。公告显示，公司本月底已发行股份数为6,282,510,461股，与上月底持平，库藏股份数量为零。\n报告期内，公司未有新增发行、购回或注销股份活动。根据公告，公司股份期权计划仍在有效期内，如全部行使，最多可额外发行628,450,646股。截至报告期末，公司确认符合相关公众持股量要求。\n上述月度报告由公司秘书温詠宜签署。公司表示将继续遵守香港联交所《上市规则》及相关法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622829545","title":"华润医药(03320)附属华润医药商业完成发行18亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2622829545","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622829545?lang=zh_cn&edition=full","pubTime":"2026-03-27 20:17","pubTimestamp":1774613828,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，公司的非全资附属公司华润医药商业集团有限公司已根据中国证券监督管理委员会的批复(证监许可[2024]1356号)于中国发行首期2026年公司债券，该批复同意华润医药商业于中国向合资格投资者公开发行本金总额不超过人民币200亿元的公司债券。董事会欣然宣布，本金额人民币18亿元的首期2026年公司债券已发行，期限3年，票面年利率为1.70%。发行首期2026年公司债券所募集的所得款项净额将用于生产性支出，包括补充营运资金、偿还计息债务、项目投资以及符合适用法律法规的其他用途。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK1191","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622846075","title":"里昂：维持华润医药(03320)“跑赢大市”评级 目标价上调至7.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846075","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622846075?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:17","pubTimestamp":1774599421,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，里昂发布研报称，维持华润医药“跑赢大市”评级，考虑到去年业绩，里昂上调华润医药2026及2027年收入预测4.1%及4.8%，纯利预测上调22.6%及15%，目标价由5.6港元上调至7.2港元。华润医药去年业绩超预期，期内收入同比增长4.6%至2,695.74亿元人民币(下同)，纯利同比增长20.7%至40.5亿元，均高于市场预期，主要受惠于制药业务表现强劲、经营开支管控较佳及融资成本下降。全年毛利率及净利润率分别扩阔0.7及0.2个百分点，至16.5%及1.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622084363","title":"招商证券国际：升华润医药(03320)目标价至6.3港元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2622084363","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622084363?lang=zh_cn&edition=full","pubTime":"2026-03-27 15:09","pubTimestamp":1774595395,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招商证券国际发布研报称，华润医药2025年制药业务部分实现收入510亿元人民币(下同)，同比增长10.2%。其中中药板块保持双位数增长，为年增13.0%，中药收入274亿元，中药处方药增速26.8%，远超OTC的5.6%，受益于天士力并表及心脑血管品种放量的结构性改善，这一趋势在今年有望延续。招商证券国际小幅提升对集团今明两年的盈利预测，目标价由5.9港元升至6.3港元，对应2026预测估值不足10倍，仍然具有吸引力;评级“增持”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06099","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622488148","title":"港股华润医药涨近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622488148","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622488148?lang=zh_cn&edition=full","pubTime":"2026-03-27 14:35","pubTimestamp":1774593349,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月27日，华润医药(03320.HK)涨近5%，截至发稿涨4.88%，报5.59港元，成交额2.48亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686936245.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686936245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","VXUS","BK4585","BK1191","03320","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168400797","title":"异动解读 | 大行唱好目标价上调，华润医药盘中大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168400797","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168400797?lang=zh_cn&edition=full","pubTime":"2026-03-27 14:32","pubTimestamp":1774593133,"startTime":"0","endTime":"0","summary":"华润医药今日盘中大涨5.25%，引起了市场的广泛关注。消息面上，招商证券国际发布研报，将华润医药的目标价由5.9元上调至6.3元，并维持“增持”评级。该行指出，公司2025年制药业务收入实现双位数增长，其中中药处方药增速显著，且管理层对2026财年收入与利润增长传递出积极信号，同时分红政策稳定，减值压力预期减小，并延续血制品领域的战略并购思路。研报认为，公司对应2026年的预测估值不足10倍，仍然具有吸引力。这些积极的财务前景与机构看好，被认为是推动股价在交易时段内显著走强的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622519668","title":"华润医药(03320)附属华润双鹤发行不超10亿元公司债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2622519668","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622519668?lang=zh_cn&edition=full","pubTime":"2026-03-26 19:03","pubTimestamp":1774523025,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，公司非全资附属公司华润双鹤药业股份有限公司(华润双鹤)已于中国向合资格投资者发行首期公司债券(2026年公司债券)，本金总额不超过人民币10亿元，期限为3年，年息率为1.65%。发行首期2026年公司债券的所得款项净额将用于偿还计息债务及补充营运资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","BK0188","BK0010","BK0175","BK0028","BK1570","600062","03320","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622833759","title":"瑞银：下调华润医药(03320)目标价至6.9港元 去年收入符预期净利润胜预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2622833759","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622833759?lang=zh_cn&edition=full","pubTime":"2026-03-26 13:46","pubTimestamp":1774503968,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，上调华润医药(03320)今年至2028年每股盈利预测14%至15%，以反映税务开支及少数股东权益减少，但同时上调资本开支预测以反映业务扩张策略。该行对华润医药的目标价由7.5港元下调至6.9港元，维持“买入”评级，相当于预测今年市盈率9.3倍。该行指，公司去年收入同比增长4.6%至2,695.6亿元人民币(下同)，股东应占净利润同比增长20.7%至40.5亿元。管理层表示若撇除减值亏损等一次性项目，净利润同比升14%。该行指出，公司去年收入符合市场预期，利润则高于预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.131},{"period":"1month","weight":-0.0807},{"period":"3month","weight":0.1391},{"period":"6month","weight":0.0522},{"period":"1year","weight":0.0946},{"period":"ytd","weight":0.1775}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.055},{"period":"3month","weight":-0.0664},{"period":"6month","weight":0.0079},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家主要从事医药业务的投资控股公司。该公司通过四个分部运营业务。制药业务分部研发、制造及销售一系列药品及保健品。药品分销业务分部向医院、分销商及零售药店等药品制造商、器械制造商及配药商提供分销、仓储、物流及其他药品供应链增值解决方案及相关服务。药品零售业务分部经营零售药店。其他业务营运分部从事持有物业及其他业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.01279},{"month":2,"riseRate":0.7,"avgChangeRate":0.045384},{"month":3,"riseRate":0.5,"avgChangeRate":0.003179},{"month":4,"riseRate":0.7,"avgChangeRate":0.030117},{"month":5,"riseRate":0.555556,"avgChangeRate":0.013028},{"month":6,"riseRate":0.333333,"avgChangeRate":0.004789},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.042472},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.002095},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.020729},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.02714},{"month":11,"riseRate":0.4,"avgChangeRate":0.010225},{"month":12,"riseRate":0.5,"avgChangeRate":-0.000929}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}